Things became litigious in 2017, when a Delaware court found that Teva's label for its generic encouraged doctors to use the drug to treat heart failure in a way that infringed GSK's RE40,000 ...

FOPI are campaigning to boycott Israeli-owned Teva, the major Irish-based generic drug producer. Irish & Northern Irish ...

Teva says it plans to file the drug with the FDA later this year in both episodic and chronic migraine, anticipating approval and launch in the second half next year. Patients in the episodic ...

Teva's Q4 earnings reveal significant headwinds, including declining U.S. generics revenue and rising costs in the API business, impacting overall profitability. Branded drugs like Austedo and ...

In 2023, brand-name obesity drugs brought in almost $6 billion ... and generic products offered by the pharmaceutical company. Teva Pharmaceuticals Industries Limited (NYSE:TEVA) is a global ...

The U.S. FDA's acceptance of a Supplemental New Drug Application for UZEDY, an extended-release injectable for maintenance treatment of bipolar I disorder, highlights Teva’s ongoing efforts in ...

Teva Pharmaceuticals recently sued the Department of Health and Human Services (HHS) and the Centers for Medicare and ...